Trusted medical search and resources
Evidence-first results
4Medical is a specialist search engine built for clinicians, researchers, patients, and healthcare buyers. It blends multiple indexes, curated content, and AI tools to make medical searches faster and more reliable. Use 4Medical to find clinical guidelines, peer-reviewed research, product specifications, local providers, and up-to-date news with filters for evidence type and source trustworthiness. Part of the 4SEARCH network of topic specific search engines.
Latest News & Web Pages
The US Probiotic Industry Has A Dirty Little Secret | Principia Scientific, Intl.
5+ hour, 51+ min ago (1592+ words) Written by A Man Of Kent on May 27, 2026. Posted in Current News America's supplement market operates on an infrastructure most consumers have never heard of. A handful of contract manufacturers produce the vast majority of what gets sold under hundreds…...
Hantavirus cruise outbreak rises with new case in Spain
5+ hour, 44+ min ago (35+ words) The West Australian is a leading news source in Perth and WA. Breaking local and world news from sport and business to lifestyle and current affairs. Hantavirus cruise outbreak rises with new case in Spain...
Video Woman turns MS diagnosis into a call to action
2+ hour, 24+ min ago (206+ words) Nancy Davis' foundation, Race to Erase MS, has been leading the charge to find a cure for multiple sclerosis for 35 years. Woman turns MS diagnosis into a call to action Nancy Davis' foundation, Race to Erase MS, has been leading…...
Dozens" of treatments for chronic itch under investigation
35+ min ago (57+ words) CLEVELAND — After more than a decade with no new medications for chronic spontaneous urticaria, clinicians are beginning to see rapid progress, according to a speaker at the Medical Dermatology Therapy Update IV. FDA approvals of the biologic dupilumab (Dupixent, Sanofi…...
Novel neurotrophin-3 inhibitor yields significant reductions in knee osteoarthritis pain
1+ hour, 5+ min ago (133+ words) A novel neurotrophin-3 inhibitor significantly reduced pain and improved function vs. placebo for patients with knee osteoarthritis, according to results presented at the Osteoarthritis Research Society International World Congress. LEVI-04 (Levicept) is a p75 neurotrophin receptor-Fc fusion protein that inhibits neurotrophin…...
Cognitive behavioral therapy may improve insomnia, hot flashes during menopause
35+ min ago (52+ words) A specially tailored cognitive behavioral therapy intervention may reduce insomnia and hot flashes among perimenopausal and postmenopausal women, researchers reported from a small pilot trial published in Menopause. Sara Nowakowski, Ph D, associate professor and psychologist at Baylor College of…...
Drinking days, education predict alcohol relapse after hepatitis
35+ min ago (61+ words) Nearly a quarter of patients who beat the high short-term mortality odds of alcohol-associated hepatitis returned to drinking within 90 days of recovery, according to study results published in Alcohol Clinical & Experimental Research. “ We were surprised by how common…...
Hospital revisit rate for COPD encounters higher after private equity acquisition
35+ min ago (62+ words) ORLANDO — In U. S. hospital encounters for COPD, there was a rise in 30-day revisits in hospitals that underwent private equity acquisition, according to data presented at the American Thoracic Society International Conference. Additionally, in encounters for pneumonia, in-hospital mortality rose…...
Heart-healthy habits may have prevented cases of severe COVID-19
13+ min ago (80+ words) Measures of ideal heart health including healthy levels of physical activity, BMI, BP and sleep were associated with lower risk for severe COVID-19 among people with no history of heart disease during the pandemic, researchers reported. For every 1 standard deviation…...
Guideline update underscores "importance of options" for colorectal cancer screening
35+ min ago (457+ words) The American Cancer Society updated its colorectal cancer screening guideline to reflect molecular-based screening tests that received regulatory approval in the past few years. The guideline — last updated in 2018 — now includes additional information about at-home multitarget stool tests....